Sort
39,280 grants matching “leukemia”
PPM1D in Clonal Hematopoiesis and Malignancies
$587,639Margaret Goodell · Baylor College Of Medicine · R01 · FY2022 · CA
PPM1D in Clonal Hematopoiesis and Malignancies
$587,639Margaret Goodell · Baylor College Of Medicine · R01 · FY2023 · CA
Targeting mitochondrial complex I in acute lymphoblastic leukemia
$587,548Marina Y Konopleva · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Dynamics of DNA-histone interactions
$587,462Tae-Hee Lee · Pennsylvania State University, The · R35 · FY2025 · GM
Retrovirus Assembly and Maturation
$587,433Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Modeling Tyrosine Kinase Inhibitor-Induced Vascular Dysfunction Using Human iPSCs
$587,417Joseph C Wu · Stanford University · R01 · FY2019 · HL
Microbiota-focused strategies to mitigate GVHD
$587,312Robert Jenq · Sloan-Kettering Inst Can Research · R01 · FY2016 · HL
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$587,298University Of Wisconsin Madison · U10 · FY2001 · CA
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
$587,189Jun J. Yang · St. Jude Children'S Research Hospital · R01 · FY2022 · CA
Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia
$587,189Jun J. Yang · St. Jude Children'S Research Hospital · R01 · FY2023 · CA
Increasing the efficacy of non-activated CAR T cells by modulating IFN1 signaling
$587,108Saba Ghassemi · University Of Pennsylvania · R01 · FY2024 · CA
Increasing the efficacy of non-activated CAR T cells by modulating IFN1 signaling
$587,108Saba Ghassemi · University Of Pennsylvania · R01 · FY2025 · CA
Immune Compromises Zebrafish for Cell Transplantation
$586,944David Michael Langenau · Massachusetts General Hospital · R24 · FY2016 · OD
Microfabricated instrumentation to measure sphingolipid signaling in human acute myeloid leukemia
$586,757Nancy L Allbritton · Univ Of North Carolina Chapel Hill · R01 · FY2019 · CA
RETROVIRUS EVOLUTION
$586,690Tufts University Boston · R01 · FY2003 · CA
Dynamic 3D chromatin remodeling in acute leukemia - Resubmission - 1
$586,658Aristotelis Tsirigos · New York University School Of Medicine · R01 · FY2024 · CA
Mechanism of perforin activity
$586,616Judy Lieberman · Immune Disease Institute, Inc. · R01 · FY2009 · AI
LAGLIDADG Delivery and Gene Repair in Canine Hematopoietic Stem Cells (7 of 11)
$586,585Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · RL1 · FY2008 · HL
Molecular Genetics of CLL
$586,428Carlo M Croce · University Of California, San Diego · P01 · FY2010 · CA
Hyperglycemia mediated myeloproliferative disease
$586,415Reuben Kapur · Indiana University Indianapolis · R01 · FY2019 · HL
The role of cytotoxic T cells in rheumatoid arthritis pathogenesis
$586,363Felipe Andrade · Johns Hopkins University · R01 · FY2023 · AR
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models
$586,205Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Pathogenic role of IL-39/IL-39R signaling in graft-versus-host disease
$586,203Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2025 · HL
Naive T cell depletion to prevent graft-versus-host disease
$586,112Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2014 · HL
Development of novel selective Rac inhibitors for refractory leukemias
$585,986David A Williams · Boston Children'S Hospital · R01 · FY2020 · CA